137 related articles for article (PubMed ID: 37961275)
21. Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia.
Liu L; Qu Q; Jiao W; Zhang Y; Li X; Ding C; Wu D
Leuk Res; 2015 Aug; 39(8):805-11. PubMed ID: 26021434
[TBL] [Abstract][Full Text] [Related]
22. How I Diagnose Acute Leukemia of Ambiguous Lineage.
Weinberg OK; Arber DA
Am J Clin Pathol; 2022 Jul; 158(1):27-34. PubMed ID: 35775438
[TBL] [Abstract][Full Text] [Related]
23. Cytogenetic aberration in mixed-phenotype acute leukemia in children: A single-center retrospective review.
Chang TY; Chen SH; Jaing TH; Yang SH; Wen YC; Yang CP; Hung IJ
Pediatr Neonatol; 2021 Jan; 62(1):21-25. PubMed ID: 32859541
[TBL] [Abstract][Full Text] [Related]
24. Leukemia With
Lin N; Yan X; Cai D; Wang L
Front Oncol; 2021; 11():709036. PubMed ID: 34395283
[TBL] [Abstract][Full Text] [Related]
25. [Immunophenotypic Features and Clinical Prognosis of Patients with Mixed Phenotype Acute Leukemia].
Liu TQ; Huang S; Li XY; Li BX; Yao B; Zhang R; Wang Y; Liu ZQ; Hu KX; Cai B; Yu CL; Qiao JH; Guo M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1305-1310. PubMed ID: 36208227
[TBL] [Abstract][Full Text] [Related]
26. Mixed Phenotype/Lineage Leukemia: Has Anything Changed for 2021 on Diagnosis, Classification, and Treatment?
Béné MC; Porwit A
Curr Oncol Rep; 2022 Aug; 24(8):1015-1022. PubMed ID: 35380407
[TBL] [Abstract][Full Text] [Related]
27. Acute leukemias of ambiguous origin.
Porwit A; Béné MC
Am J Clin Pathol; 2015 Sep; 144(3):361-76. PubMed ID: 26276768
[TBL] [Abstract][Full Text] [Related]
28. Mixed phenotype acute leukemia.
Ye Z; Wang S
Chin Med J (Engl); 2014; 127(16):2999-3003. PubMed ID: 25131241
[TBL] [Abstract][Full Text] [Related]
29. Importance of CD117 in the Assignation of a Myeloid Lineage in Acute Leukemias.
Pomerantz A; Rodríguez-Rodríguez S; Demichelis-Gómez R; Barrera-Lumbreras G; Barrales-Benítez OV; Díaz-Huízar MJ; Goldberg-Murow M; López-Karpovitch X; Aguayo Á
Arch Med Res; 2017 Feb; 48(2):212-215. PubMed ID: 28625325
[TBL] [Abstract][Full Text] [Related]
30. Allogeneic hematopoietic stem cell transplantation for adult patients with mixed phenotype acute leukemia: results of a matched-pair analysis.
Shimizu H; Saitoh T; Machida S; Kako S; Doki N; Mori T; Sakura T; Kanda Y; Kanamori H; Miyawaki S; Okamoto S;
Eur J Haematol; 2015 Nov; 95(5):455-60. PubMed ID: 25605541
[TBL] [Abstract][Full Text] [Related]
31. Optimal therapeutic strategies for mixed phenotype acute leukemia.
Wolach O; Stone RM
Curr Opin Hematol; 2020 Mar; 27(2):95-102. PubMed ID: 31913151
[TBL] [Abstract][Full Text] [Related]
32. Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force.
Orgel E; Alexander TB; Wood BL; Kahwash SB; Devidas M; Dai Y; Alonzo TA; Mullighan CG; Inaba H; Hunger SP; Raetz EA; Gamis AS; Rabin KR; Carroll AJ; Heerema NA; Berman JN; Woods WG; Loh ML; Zweidler-McKay PA; Horan JT;
Cancer; 2020 Feb; 126(3):593-601. PubMed ID: 31661160
[TBL] [Abstract][Full Text] [Related]
33. Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage.
Montefiori LE; Mullighan CG
Best Pract Res Clin Haematol; 2021 Dec; 34(4):101329. PubMed ID: 34865701
[TBL] [Abstract][Full Text] [Related]
34. Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis.
Maruffi M; Sposto R; Oberley MJ; Kysh L; Orgel E
Leukemia; 2018 Jul; 32(7):1515-1528. PubMed ID: 29550836
[TBL] [Abstract][Full Text] [Related]
35.
Xiao W; Bharadwaj M; Levine M; Farnhoud N; Pastore F; Getta BM; Hultquist A; Famulare C; Medina JS; Patel MA; Gao Q; Lewis N; Pichardo J; Baik J; Shaffer B; Giralt S; Rampal R; Devlin S; Cimera R; Zhang Y; E Arcila M; Papaemmanuil E; Levine RL; Roshal M
Blood Adv; 2018 Dec; 2(23):3526-3539. PubMed ID: 30530780
[TBL] [Abstract][Full Text] [Related]
36. Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated
Nguyen L; Zhang X; Roberts E; Yun S; McGraw K; Abraham I; Song J; Braswell D; Qin D; Sallman DA; Lancet JE; List AF; Moscinski LC; Padron E; Zhang L
Leuk Lymphoma; 2020 Jun; 61(6):1395-1405. PubMed ID: 32091281
[TBL] [Abstract][Full Text] [Related]
37. Repeated Lineage Switches in an Elderly Case of Refractory B-Cell Acute Lymphoblastic Leukemia With
Takeda R; Yokoyama K; Fukuyama T; Kawamata T; Ito M; Yusa N; Kasajima R; Shimizu E; Ohno N; Uchimaru K; Yamaguchi R; Imoto S; Miyano S; Tojo A
Front Oncol; 2022; 12():799982. PubMed ID: 35402256
[TBL] [Abstract][Full Text] [Related]
38. Mixed Phenotype Acute Leukemia: Current Approaches to Diagnosis and Treatment.
Alexander TB; Orgel E
Curr Oncol Rep; 2021 Feb; 23(2):22. PubMed ID: 33544265
[TBL] [Abstract][Full Text] [Related]
39. Multiparameter flow cytometry applications in the diagnosis of mixed phenotype acute leukemia.
Porwit A; Béné MC
Cytometry B Clin Cytom; 2019 May; 96(3):183-194. PubMed ID: 31033213
[TBL] [Abstract][Full Text] [Related]
40. Mixed-Phenotype Acute Leukemia: Clinical Diagnosis and Therapeutic Strategies.
George BS; Yohannan B; Gonzalez A; Rios A
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
